BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 28111363)

  • 1. Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass.
    Maanja M; Wieslander B; Schlegel TT; Bacharova L; Abu Daya H; Fridman Y; Wong TC; Schelbert EB; Ugander M
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28111363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).
    Inoue YY; Ambale-Venkatesh B; Mewton N; Volpe GJ; Ohyama Y; Sharma RK; Wu CO; Liu CY; Bluemke DA; Soliman EZ; Lima JA; Ashikaga H
    Radiology; 2017 Mar; 282(3):690-698. PubMed ID: 27740904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The electrical determinants of increased wall thickness and mass in left ventricular hypertrophy.
    Maanja M; Schlegel TT; Kozor R; Lundin M; Wieslander B; Wong TC; Schelbert EB; Ugander M
    J Electrocardiol; 2020; 58():80-86. PubMed ID: 31785580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
    Vernooij JW; Cramer MJ; Visseren FL; Korndewal MJ; Bots ML; Meijs MF; Doevendans PA; Spiering W;
    Am J Cardiol; 2012 Jul; 110(2):227-33. PubMed ID: 22483385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
    J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.
    Ambale Venkatesh B; Volpe GJ; Donekal S; Mewton N; Liu CY; Shea S; Liu K; Burke G; Wu C; Bluemke DA; Lima JA
    Hypertension; 2014 Sep; 64(3):508-15. PubMed ID: 24914198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravital and postmortem diagnostics of myocardial hypertrophy of the left ventricle:identity or convention?
    Bogomolov SN; Kulikov AN; Tikhonova JA; Solntsev VN; Rybakova MG; Gudkova AY; Kuchmin AN
    Ter Arkh; 2018 Sep; 90(9):73-80. PubMed ID: 30701739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
    Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
    Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study.
    Rodrigues JC; Amadu AM; Ghosh Dastidar A; McIntyre B; Szantho GV; Lyen S; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
    Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):441-450. PubMed ID: 27334442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
    Xie L; Wang Z
    Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peguero-Lo Presti criteria for diagnosis of left ventricular hypertrophy: a cardiac magnetic resonance validation study.
    Guerreiro C; Azevedo P; Ladeiras-Lopes R; Ferreira N; Barbosa AR; Faria R; Almeida J; Primo J; Melica B; Braga P
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):437-443. PubMed ID: 32251077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetocardiographic indices of left ventricular hypertrophy.
    Karvonen M; Oikarinen L; Takala P; Kaartinen M; Rossinen J; Hänninen H; Montonen J; Nenonen J; Mäkijärvi M; Keto P; Toivonen L; Nieminen MS; Katila T
    J Hypertens; 2002 Nov; 20(11):2285-92. PubMed ID: 12409968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.